The American Society for Radiation Oncology issues an updated clinical practice guideline in Practical Radiation Oncology recommending moderate hypofractionated radiation therapy across all localized prostate cancer risk groups.
Tag: prostate cancer
Late-breaking: Novel alpha radiopharmaceutical therapy shows promising activity in phase 1 prostate cancer trial
The Phase 1 TheraPb clinical trial demonstrates that weekly dosing of 212Pb-ADVC001 is well tolerated and shows early antitumor activity in advanced prostate cancer patients.
Time to Relabel Low-Risk Prostate Cancer to Remove Stigma and Reduce Overtreatment
Researchers argued in a medical journal that renaming low-risk prostate cancer would reduce unnecessary anxiety and overtreatment in newly diagnosed patients.